Product Information
SEROQUEL 300 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $15.9090 per EA under NDC 00310027460. Its NADAC has been published 276 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the quetiapine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310027460
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA020639On Market Since
11/13/2000
Pharmacological Classes
Price Statistics
The NADAC for SEROQUEL 300 MG TABLET has been published 276 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.9090 per EA |
|---|---|
| All-time high | $16.1771 (Dec 11, 2013) |
| All-time low | $15.7087 (May 22, 2024) |
| 52-week high | $15.9090 |
| 52-week low | $15.8109 |
| Median price | $15.8868 |
| Average price | $15.8919 |
| Largest weekly change | -1.4% (Apr 17, 2024) |
| Weeks tracked | 276 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SEROQUEL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEROQUEL 300 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $15.9090 per EA (NDC 00310027460), effective Jun 24, 2026.
How has the price of SEROQUEL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEROQUEL 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 276 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SEROQUEL 300 MG TABLET?
Since Nov 28, 2013, the NADAC for SEROQUEL 300 MG TABLET has ranged from a low of $15.7087 (May 22, 2024) to a high of $16.1771 (Dec 11, 2013), with a median of $15.8868 per EA.
Are there cheaper alternatives to SEROQUEL 300 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1442 per EA — about 99% below SEROQUEL 300 MG TABLET.
Who manufactures SEROQUEL 300 MG TABLET?
SEROQUEL 300 MG TABLET (NDC 00310027460) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification